After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Exelixis Announces Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Corporate Update.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $21.96 and fluctuated between $21.99 as its day high and $21.49 as its day low. The current market capitalization of Exelixis Inc is $6.66B. A total of 2.26 million shares were traded on the day, compared to an average of 2.16M shares.
Insider Activity
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, EXEL has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 30 BUYs and 35 SELLs from insiders. Insiders purchased 2,381,590 shares during that period but sold 1,228,385.
In the most recent transaction, JOHNSON DAVID EDWARD bought 190,000 shares of EXEL for 20.70 per share on Feb 21. After the transaction, the Director now owns 1,100,730 company shares. In a previous transaction on Dec 14, Haley Patrick J. sold 50,000 shares at 23.35 per share. EXEL shares that EVP, Commercial owns now total 307,687.
Among the insiders who sold shares, Hessekiel Jeffrey disposed of 25,000 shares on Dec 13 at a per-share price of $23.01. This resulted in the EVP, General Counsel & Sec holding 533,345 shares of EXEL after the transaction. In another insider transaction, Haley Patrick J. sold 14,149 shares at $22.50 per share on Dec 12. Company shares held by the EVP, Commercial now total 307,687.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for EXEL in the last 3 months, the mean price target is $26.74 with high estimates of $32.00 and low estimates of $18.00. In terms of 52-week highs and lows, EXEL has a high of $24.34 and a low of $16.15.
As of this writing, EXEL has an earnings estimate of $0.23 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $0.47 per share and a lower estimate of $0.11. The company reported an EPS of $0 in the last quarter, which was -100.00% lower than expectations of $0.09.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EXEL’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $51.27M in debt and $337.59M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $2.21B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXEL is Buy with a score of 4.63.
